Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven G Deeks

Showing results (641-650 of 663) with videos related to

Pageof 67
Sort By:
Plos Pathogens|September 12, 2022
Infectious viral shedding of SARS-CoV-2 Delta following vaccination: A longitudinal cohort studyMiguel Garcia-Knight, Khamal Anglin, Michel Tassetto, et al.
The New England Journal of Medicine|April 3, 2009
Effect of early versus deferred antiretroviral therapy for HIV on survivalMari M Kitahata, Stephen J Gange, Alison G Abraham, et al.
Science Immunology|June 3, 2018
Identification and characterization of HIV-specific resident memory CD8<sup>+</sup> T cells in human lymphoid tissueMarcus Buggert, Son Nguyen, Gonzalo Salgado-Montes de Oca, et al.
Statistics in Medicine|March 19, 2019
Emulating a trial of joint dynamic strategies: An application to monitoring and treatment of HIV-positive individualsEllen C Caniglia, James M Robins, Lauren E Cain, et al.
The Lancet. HIV|April 16, 2017
Comparison of dynamic monitoring strategies based on CD4 cell counts in virally suppressed, HIV-positive individuals on combination antiretroviral therapy in high-income countries: a prospective, observational studyEllen C Caniglia, Lauren E Cain, Caroline A Sabin, et al.
Nature|July 19, 2023
A common allele of HLA is associated with asymptomatic SARS-CoV-2 infectionDanillo G Augusto, Lawton D Murdolo, Demetra S M Chatzileontiadou, et al.
Medrxiv : the Preprint Server for Health Sciences|March 10, 2021
SARS-CoV-2 antibody magnitude and detectability are driven by disease severity, timing, and assayMichael J Peluso, Saki Takahashi, Jill Hakim, et al.
The Lancet. HIV|March 20, 2019
Recommendations for analytical antiretroviral treatment interruptions in HIV research trials-report of a consensus meetingBoris Julg, Lynda Dee, Jintanat Ananworanich, et al.
Science Advances|July 31, 2021
SARS-CoV-2 antibody magnitude and detectability are driven by disease severity, timing, and assayMichael J Peluso, Saki Takahashi, Jill Hakim, et al.
Science (New York, N.Y.)|October 26, 2006
A plea for justice for jailed medical workersSunil K Ahuja, Fernando Aiuti, Ben Berkhout, et al.
Pageof 67

Showing results (641-650 of 663) with videos related to

Sort By:
Pageof 67
Plos Pathogens|September 12, 2022
Infectious viral shedding of SARS-CoV-2 Delta following vaccination: A longitudinal cohort studyMiguel Garcia-Knight, Khamal Anglin, Michel Tassetto, et al.
The New England Journal of Medicine|April 3, 2009
Effect of early versus deferred antiretroviral therapy for HIV on survivalMari M Kitahata, Stephen J Gange, Alison G Abraham, et al.
Science Immunology|June 3, 2018
Identification and characterization of HIV-specific resident memory CD8<sup>+</sup> T cells in human lymphoid tissueMarcus Buggert, Son Nguyen, Gonzalo Salgado-Montes de Oca, et al.
Statistics in Medicine|March 19, 2019
Emulating a trial of joint dynamic strategies: An application to monitoring and treatment of HIV-positive individualsEllen C Caniglia, James M Robins, Lauren E Cain, et al.
The Lancet. HIV|April 16, 2017
Comparison of dynamic monitoring strategies based on CD4 cell counts in virally suppressed, HIV-positive individuals on combination antiretroviral therapy in high-income countries: a prospective, observational studyEllen C Caniglia, Lauren E Cain, Caroline A Sabin, et al.
Nature|July 19, 2023
A common allele of HLA is associated with asymptomatic SARS-CoV-2 infectionDanillo G Augusto, Lawton D Murdolo, Demetra S M Chatzileontiadou, et al.
Medrxiv : the Preprint Server for Health Sciences|March 10, 2021
SARS-CoV-2 antibody magnitude and detectability are driven by disease severity, timing, and assayMichael J Peluso, Saki Takahashi, Jill Hakim, et al.
The Lancet. HIV|March 20, 2019
Recommendations for analytical antiretroviral treatment interruptions in HIV research trials-report of a consensus meetingBoris Julg, Lynda Dee, Jintanat Ananworanich, et al.
Science Advances|July 31, 2021
SARS-CoV-2 antibody magnitude and detectability are driven by disease severity, timing, and assayMichael J Peluso, Saki Takahashi, Jill Hakim, et al.
Science (New York, N.Y.)|October 26, 2006
A plea for justice for jailed medical workersSunil K Ahuja, Fernando Aiuti, Ben Berkhout, et al.
Pageof 67